0.6110EUR0.00%Mkt Cap: 47.76M EURP/E: —Last update: 2026-05-29
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offe…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap47.76M EUR
Enterprise Value69.04M EUR
Revenue (TTM)0 EUR
Gross Profit79.06K EUR
Net Income (TTM)-44.65M EUR
Revenue/Share0.0000 EUR
Last Price0.6110 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees48
CountryBE
SectorHealthcare
IndustryMedical Devices
ISINBE0974340722
Valuation
P/E (Trailing)—
P/E (Forward)-1.67
PEG—
EV/EBITDA-4.01
EV/Revenue—
P/SInfinity
P/B-0.89
EPS (TTM)-1.23
EPS (Forward)-0.36
52W Range
0.460013% of range1.618
52W High1.618 EUR
52W Low0.4600 EUR
Profitability
Gross Margin74.94%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-42325.70%
ROE100.62%
ROA-449.06%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.26M EUR
CapEx (TTM)95.13K EUR
FCF Margin—
FCF Yield-27.24%
Net Debt34.09M EUR
Net Debt/EBITDA-1.98
Balance Sheet
Debt/Equity-0.90
Current Ratio0.20
Quick Ratio0.15
Book Value/Sh-0.6850 EUR
Cash/Share0.1280 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.500 EUR
Target Range1.500 EUR – 1.500 EUR
# Analysts1
Ownership
Shares Out.78.17M
Float34.99M
Insiders13.16%
Institutions28.93%
Technical
SMA 500.5553 (+10.0%)
SMA 2000.6697 (-8.8%)
Beta-0.29
S&P 52W Chg27.94%
Avg Vol (30d)85.57K
Avg Vol (10d)0
Technical Indicators
RSI (14)68.9
MACD0.0144
MACD Signal0.0180
MACD Hist.-0.0036
BB Upper0.6110 EUR
BB Middle0.6110 EUR
BB Lower0.6110 EUR
BB Width0.00%
ATR (14)0.0087 EUR
Vol Ratio (20d)—